Local view for "http://purl.org/linkedpolitics/eu/plenary/2003-12-16-Speech-2-269"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20031216.6.2-269"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Mr President, may I add my voice to the fully deserved congratulations my fellow Members have offered to the two rapporteurs, Mrs Grossetête and Mrs Müller? We can agree that what we have here is a hard-won compromise, a compromise in which a large number of Parliament’s wishes, in particular, are also fulfilled.
It is not Parliament who is the winner here, however. The winner is the citizen, who will soon be given the possibility of obtaining a good supply of medicinal products, quickly and efficiently.
A compromise cannot be achieved, however, without some watering down. I accept that it is not possible to win on every point. May I add some criticisms, however? The first relates to the decision on pharmacists that was taken in the compromise. I understand that that amendment did not fit in the legislation as it stood. A good supply of medicinal products also requires, however, that pharmacists make their know-how available, not only to patients, but also, in particular, to those writing out the prescriptions.
That is an omission. If we do not regulate this here and now, I shall fight for its regulation in further legislation dealing with the quality of health care. As far as I am concerned, it must not be the case that the only places still concerned with medicinal products are supermarkets, because it is cheaper that way.
My second point concerns homeopathic medicinal products. On this subject, the compromise achieved does all users of these medicinal products a great injustice. I ask myself why the compromise that has now been achieved would fail if we now voted for a couple of original amendments, such as Amendment No 20. I know that some fellow Members have requested a separate vote. I have the feeling that we are failing to answer the questions of many on that point.
I should like a definite answer to the following question. Why do we not go further with these homeopathic medicinal products? After all, what has now been adopted in this compromise does not by any means present a solution. I am genuinely sad about this.
My next point concerns Doha and medicinal products. I agree with Mrs Corbey’s comments. Unlike my fellow MEP Mr Liese, I think that it is a shame that we still do not consider our European citizens fit for independence when it comes to information on medicinal products. I am not in favour of advertising; I am, however, in favour of information. I think that an independent citizen should be able to obtain the information he or she needs in Europe, too, instead of being redirected from the website of a European undertaking to that of a US undertaking to find this information. I think that that is a shame. We have missed an opportunity. Those were my remarks, and I should like an answer from the Commission regarding homeopathy."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples